Stay updated on Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new Locations section with state-level sites was added, and the previous state-specific subsections (California, Illinois, Maryland, Missouri, New York, Pennsylvania, Tennessee) were removed. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.8%
    Check dated 2025-12-23T22:05:23.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The Publications note now states that entries are automatically filled from PubMed and may not all be about the study, and the Revision is updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:44.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The funding-status notice about potential delays due to government funding has been removed. Core study details remain visible.
    Difference
    0.4%
    Check dated 2025-11-18T07:24:06.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The new page shows only minor visual/layout updates; substantive study data (enrollment, locations, eligibility criteria, outcomes) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T20:59:05.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic: Head and neck squamous cell carcinoma.
    Difference
    0.5%
    Check dated 2025-10-20T17:17:57.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Core content now notes current operating status and directs to official status sources, and introduces version 3.2.0 while removing the old 3.1.0.
    Difference
    5%
    Check dated 2025-10-06T08:11:52.000Z thumbnail image

Stay in the know with updates to Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page.